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Background: The dysregulated cytokine metabolism and activity are crucial to the development of fulminant
hepatic failure (FHF), and many different cytokines have been identified. However, the precise gene expression
profile and their interactions association with FHF are yet to be further elucidated.
Methods: In this study, we detected the digital gene expression profile (DGEP) by high-throughput sequencing in
normal and FHF mouse liver, and the candidate genes and potential targets for FHF therapy were verified. And the
FHF mouse model was induced by D-Galactosamine (GalN)/lipopolysaccharide (LPS).
Results: Totally 12727 genes were detected, and 3551 differentially expressed genes (DEGs) were obtained from
RNA-seq data in FHF mouse liver. In FHF mouse liver, many of those DEGs were identified as differentially expressed
in metabolic process, biosynthetic process, response to stimulus and response to stress, etc. Similarly, pathway
enrichment analysis in FHF mouse liver showed that many significantly DEGs were also enriched in metabolic
pathways, apoptosis, chemokine signaling pathways, etc. Considering the important role of nuclear factor-kappa
B (NF-κB) in metabolic regulation and delicate balance between cell survival and death, several DEGs involved in
NF-κB pathway were selected for experimental validation. As compared to normal control, NF-κBp65 and its
inhibitory protein IκBα were both significantly increased, and NF-κB targeted genes including tumor necrosis factor
α(TNFα), inducible nitric oxide synthase (iNOS), interleukin-1β, chemokines CCL3 and CCL4 were also increased
in hepatic tissues of FHF. In addition, after NF-κB was successfully pre-blocked, there were significant alteration of
hepatic pathological damage and mortality of FHF mouse model.
Conclusions: This study provides the globe gene expression profile of FHF mouse liver, and demonstrates the
possibility of NF-κB gene as a potential therapeutic target for FHF.
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Fulminant hepatic failure (FHF) is a severe, life-threatening
disorder, which is characterized by a dramatic clinical
syndrome resulting from massive hepatocyte death
[1,2]. There is a large number of evidence showing
that the dysregulated cytokine metabolism and activity
are crucial to the progression of liver damage and the* Correspondence: htang6198@hotmail.com
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unless otherwise stated.regulation of undesired inflammation is an attractive
potential strategy in the treatment of FHF [3-5].
Though many different cytokines have been identified,
the precise gene expression profile and their interac-
tions in FHF are yet to be further elucidated.
In past decade, expression microarrays have been ap-
plied for genome-wide expression analysis for identifica-
tion of differentially expressed genes (DEGs) associated
with liver injury [6]. Although these studies provided
new information regarding gene expression patterns in
FHF, interactions between genes and affected pathways
may have been missed because of technical limitations.
Recently, by the rapid development of a “secondhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Chen et al. Journal of Translational Medicine  (2015) 13:22 Page 2 of 11generation” of sequencing technologies, the digital
gene expression profile (DGEP) method was made
[7-9], and millions of expression tags can be measured
simultaneously at a fraction of the cost of capillary
sequencing used in the original serial analysis of
gene expression method. A major advantage of DGEP,
which overcomes the drawbacks of using predesigned
hybridization probes as in microarray-based methods,
is that it allows detection of expressed genes in a
strand-specific manner; and DGEP method provides
information on the polarity of the expressed tran-
scripts, allowing detection of sense and antisense tran-
scripts from the same gene region.
At present, DGEP experiments often involve measur-
ing the relative amount of mRNA expressed in two or
more experimental conditions. This is because altered
levels of a specific sequence of mRNA suggest a changed
need for the protein coded for by the mRNA, perhaps
indicating a homeostatic response or a pathological con-
dition [10]. For example, if injured hepatic cells express
higher levels of mRNA associated with a particular cyto-
kine than normal cells do, it might be that this cytokine
plays a role in hepatic injuries. Thus, the application of
DGEP in transcriptome profiling of severe injured liver
tissue is important to further understand the underlying
mechanisms of FHF.
D-Galactosamine (GalN)/lipopolysaccharide (LPS)-in-
duced liver failure in mice is dependent on macrophage-
derived pro-inflammatory cytokines, including tumor
necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6 and
interferon-γ, and accurately represents human FHF [11].
Thus, in this study, we detected global gene expression
profile in normal and FHF mouse liver by DGEP
method, and showed the main FHF-associated hepatic
biological processes, pathways, and key molecules poten-
tially serving as important therapeutic target for FHF.
Materials and methods
Animal experiments
Male BALB/c mice, 18–22 g, were obtained from
Sichuan University (Chengdu, China). They were housed
and cared for in rooms maintained at a constant
temperature and humidity. Food and water were allowed
ad libitum. Food was withdrawn the evening before the
experiment. In this study, animal experiments involved
in screening of DEGs in FHF mouse liver (Part. 1), and
verification of some potential candidate genes related to
the progression of FHF (Part. 2). In part. 1, a mouse
model of FHF was established by intraperitoneal injec-
tions of D-GalN (800 mg/kg body weight; Sigma, Saint
Louis, USA) and LPS (20 μg/kg body weight; Sigma), as
described previously. Control mice were intraperitoneally
injected with saline. Plasma and liver tissue samples were
obtained 6 h after injection and were stored at -80°C untilanalysis. In part. 2, a potent NF-κB chemical inhibitor pyr-
rolidine dithiocarbamate (PDTC) was given by intraperito-
neal injection to pre-block of NF-κB activation and
expression, 12 h before D-GalN/LPS administration; and
the plasma and liver tissue samples were also obtained 6 h
after the construction of FHF mouse liver, and were stored
at -80°C until analysis.
Sample preparation and solexa library construction
Liver samples were ground in liquid nitrogen, and total
RNA was extracted with Trizol reagent (Invitrogen). The
integrity of total RNA was evaluated using an Agilent
Bioanalyzer 2100. Solexa libraries were constructed fol-
lowing the manufacturer’s standard according to the sche-
matic as described previously.
Solexa sequencing and data analysis
The image files obtained from Illumina 1G sequencer
were processed to produce sequence data. Then the
high-quality reads were screened from the original raw
data, and the adaptors were removed from each se-
quence. Subsequently, high quality clean tags were com-
pared with RefSeq database and the expression level of
each gene was normalized to transcripts per million
(TPM). The significance of DGEP was analyzed as de-
scribed previously. The expression pattern of these
DEGs was visualized using the heat-map function in the
R base package. In this study, to avoid the possible noise
signal from high-throughput sequencing, the genes with
an average TPM less than 1 were excluded; and the
remained genes were used to calculate the fold changes
and false discovery rate (FDR). And the absolute fold
change no less than 1(|log2Ratio| ≥ 1) and FDR less than
0.001 were used to define the DEGs.
Gene ontology functional and pathway enrichment
analysis for DEGs
The clustered genes were assigned to molecular func-
tion, cellular component and biological process based on
Gene Ontology using the web tool DAVID (http://david.
abcc.ncifcrf.gov/home.jsp). Hypergeometric test was used
to select the enriched molecular function, cellular compo-
nent and biological process in Gene Ontology for each
cluster. The pathways associated with these gene clusters
were analyzed by KEGG (www.genome.jp/kegg/pathway.
html).
Detection of NF-κBp65 and its inhibitory protein IκBα in
liver tissue
The protein expression levels of NF-κBp65 and its in-
hibitory protein IκBα in liver tissue were determined
by western blot analysis, according to the standard
manufacturer’s protocol. And the rabbit polyclonal
anti-NF-κBp65 (Abcam, England) and anti-IκBα antibodies
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polyclonal anti-GAPDH antibody (ProteinTech, USA) was
diluted at 1:1000 as a control. Immunodetection was per-
formed with the ECL-Plus kit (Pierce Biotechnology, USA),
and immunoblot signals were quantified using Quantity
One Software (Bio-Rad).
Biochemistry and plasma protein analysis
In order to assess the extent of liver injury, serum ala-
nine aminotransferase (ALT), aspertate aminotransferase
(AST), total bilirubin (TBil) and indirect bilirubin (IBil)
were measured with automatic analyzer (HITACHI, Japan).
Serum levels of TNF-α were measured by enzyme-linked
immunosorbent assay (GenStar BioSolutions, China), with
lower limits of detection of 7 pg/mL.
Determination of mRNA levels for candidate genes in
liver tissue
Total RNA was extracted from frozen liver tissue with
TRIzol Reagent (Invitrogen, USA). Total cellular RNA was
reverse-transcribed using Moloney Murine Leukemia
Virus (MMLV) reverse transcriptase (Gibco BRL, USA).
Blank reactions with no RNA were performed in all exper-
iments. The expression of candidate genes mRNA was
measured in liver tissues by real-time PCR using Maxima
SYBR green/ROX qPCR Master Mix (Fermentas Life
Sciences, Canada). The primer sequences a of β-actin (the
reference) and candidate genes obtained from DGE profil-
ing experiment are listed in Table 1. And the fold changes
of the expression of the candidate genes relative to the
reference gene were calculated using the normalized ex-
pression (ΔCt) method with default threshold values using
CFX Manager Software (Bio-Rad).Table 1 Primer sequences used in the quantitative RT-PCR an
Gene Length Forward prime
TNFα 183 bp CCCTCCAGAAA
TNFr 172 bp GCAAAATCCCC
IκBα 180 bp CCCTTACTGGA
iNos 215 bp GGGAATCTTGG
TLR7 141 bp GTTCTATGGAG
Ccl3 152 bp CACTGCCCTTG
Ccl4 162 bp TCTCTCTCCTCT
Bid 189 bp CAGACCTGCTG
Bcl2 154 bp CTGAGAGAGGC
C5a 158 bp CATTGCTCCTCA
Egr2 154 bp GCCCCTTTGAC
Fos 157 bp TGACAGATACA
Junb 182 bp AGTTACTCCCCA
Map3k5 192 bp GCCTAAACTAA
β-actin 263 bp GAGACCTTCAAHistological assessment
Liver tissue sections (paraffin embedded) were stained
with hematoxylin-eosin using a standard protocol, and
analyzed by light microscopy under 400-fold magnifica-
tion. Morphological criteria including vacuolization,
swollen cytoplasm with disrupted cell and organelle
membranes, and lytic nuclear changes served to determine
necrosis. Hepatocyte apoptosis was assessed by the
TUNEL assay kit (Roche, Switzerland). The protein ex-
pression of TNFα and iNOS in liver tissue was detected by
immunohistochemistry; and the percentage of positive
cells and the positive staining intensity were checked and
scored using the Axiotis score standard by observation of
5 randomly chosen fields at 400-fold magnification [12].
The primary anti-TNFα and anti-iNOS antibodies were
purchased from Cell Signaling Technology (USA). In this
study, the liver histology was assessed by a single patholo-
gist, unaware of the laboratory data.
Statistical analysis
All animal experiments were done in triplicate, and
the results were expressed as mean ± SD. Statistical
comparisons were made by 1-way analysis of variance
using SPSS 17.0 (SPSS Inc, Chicago, IL). The differences
were considered statistically significant if P value less
than 0.05.
Results
High-throughput sequencing data and DEGs in FHF
mouse liver
To obtain an overview of the gene expression profile in
the development of fulminant hepatic failure, cDNA

















Chen et al. Journal of Translational Medicine  (2015) 13:22 Page 4 of 11the intraperitoneal injections of GalN/LPS, Figure 1-A1)
and normal control mouse (Figure 1-B1), and then se-
quenced by using the Illumina sequencing platform. We
obtained over 6.15 million and 5.88 million sequenced
tags from normal and FHF liver, respectively. After filter-
ing the adaptor sequences and removing the low-quality
tags (including the tag with less than two copy), about
5.97 million (Figure 1-B2) and 5.67 million (Figure 1-A2)
clean tags were left in the two libraries and used for
further analysis, respectively; and there were about 4.12
million unique tags(68.99% of clean tags, Figure 1-B3)
in normal control and 3.63 million unique tags (64.08%
of clean tags, Figure 1-A3) in FHF model could be
mapped to annotated mouse genes. Finally, 12611
(35.37% of reference genes, Figure 1-B4) and 13167
(35.93% of reference genes, Figure 1-A4) unique genes
were detected and quantified from normal and FHF
liver samples, respectively.
The distribution of gene expression between FHF and
normal control mouse were presented in Figure 2A. The
number of DEGs was quantified among above unique
genes, and the absolute fold change no less than 1 and
FDR less than 0.001 were used to define the DEGs.
According to this definition, totally 3551 genes (includ-
ing 1366 up-regulated and 2185 down-regulated) were
differentially expressed between normal and FHF mouse
liver sample (Figure 2B and C). In this study, Cxcl2 (che-
mokine [C-X-C motif] ligand 2), Rn7sk (RNA, 7SK, nu-
clear), Ccl2 (chemokine [C-C motif] ligand 2), Gm12238
(predicted gene 12238), Snora44 (small nucleolar RNA,
H/ACA box 44), Cilp2 (cartilage intermediate layer pro-
tein 2), Ccl5, Ccl7, Ccl3 and Snora5c (small nucleolar
RNA, H/ACA box 5C) were in the top 10 fold changeFigure 1 Sequencing and mapping messages of hepatic mRNA profili
(FHF) group, B: Normal control (NC) group]. (A1 and B1) The mouse liv
(A2 and B2) The distribution of total tags in two libraries. (A3 and B3) The m
genes mapped by all clean tags(solid line) and unique clean tags (broken linegenes up-regulated in FHF mouse liver (Figure 2D),
while Spata2L (spermatogenesis associated 2-like), Acot3
(acyl-CoA thioesterase 3), Nags(N-acetylglutamate syn-
thase), Abhd15 (abhydrolase domain containing 15),
Hist1 (histone cluster 1), Cxxc5 (CXXC finger 5), Aacs
(acetoacetyl-CoA synthetase), C1s (complement compo-
nent 1), Cyp4 (cytochrome P450, family 4), and Ptma
(prothymosin alpha) were in the top 10 fold change genes
down-regulated in FHF mouse liver (Figure 2E). The full
list of DEGs was added as supplemental Table 1.The main biological processes and pathways altered in
FHF mouse liver
To investigate the possible biologic functions of the
genes affected in FHF mouse liver, the above 1366 up-
regulated and 2185 down-regulated DEGs were analyzed
by Gene Ontology, and partial typical biological process,
cellular componsent and molecular function were pre-
sented in Figure 3. Among biological process, DGEs
were strongly enriched metabolic process, biosynthetic
process, response to stimulus and response to stress,
with 1527, 744, 579, and 365 genes, respectively.
Furthermore, KEGG pathway analysis was performed
to further elucidate the biological functions of the
gene clusters affected in FHF mouse liver, and a partial
list of pathways significantly altered in FHF mouse
liver was shown in Table 2, and following metabolic
pathway (id: ko01100), peroxisome (id: ko04380),
apoptosis (id: ko04210), adipocytokine signaling path-
way (id: ko04920), chemokine signaling pathway (id:
ko04062), and toll-like receptor signaling pathway(id:
ko04620) were all involved.ng of normal and FHF mouse liver [A: fulminant hepatic failure
er samples used to prepare the high-throughput sequencing libraries.
apping of total clean tags in two libraries. (A4 and B4) Accumulation the
) in two libraries.
Figure 2 The distribution of differentially expressed genes in FHF library. (A) Distribution of gene expression between FHF (left) and NC
groups (right). (B) Comparison of gene expression between FHF and NC libraries. (C) Distribution of DEGs by fold changes. (D) The top 30
up-regulated DEGs in FHF mouse liver. (E) The top 30 down-regulated in FHF mouse liver.
Chen et al. Journal of Translational Medicine  (2015) 13:22 Page 5 of 11The DEGs regulated by nuclear factor κB in FHF
mouse liver
In FHF, the hepatocytes were severely damaged and or-
dinary liver regeneration was impaired (Figure 1-A1),but the exact mechanism had not been fully elucidated.
Since nuclear factor κB (NF-κB) family of transcription
factors governed the cellular reaction to a variety of
extracellular signals, which activated genes involved in
Figure 3 Histogram presentation of Gene Ontology classification. The results are summarized in three main categories: biological process,
cellular component and molecular function. The upper half of y-axis indicates the number (up) and percentage (down) of genes in a category,
and the lower half of y-axis indicates the percentage of a specific category of genes in that main category.




DEGs tested P value
Metabolic pathways ko01100 396(15.03%) 2.22e-17
Peroxisome ko04146 45(1.71%) 2.34e-07
ABC transporters ko02010 24(0.91%) 9.89e-07
Protein processing in endoplasmic
reticulum
ko04141 69(2.62%) 2.25e-06
Apoptosis ko04210 39(1.48%) 1.59e-05
Drug metabolism - other enzymes ko00983 28(1.06%) 1.98e-05
Chemokine signaling pathway ko04062 76(2.89%) 4.80e-05
Adipocytokine signaling pathway ko04920 37(1.40%) 0.0001
Toll-like receptor signaling pathway ko04620 44(1.67%) 0.0001
Pantothenate and CoA biosynthesis ko00770 10(0.38%) 0.0002
Fructose and mannose metabolism ko00051 21(0.80%) 0.0003
Ascorbate and aldarate metabolism ko00053 14(0.53%) 0.0003
Steroid biosynthesis ko00100 12(0.46%) 0.0003
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homeostasis, etc. In this study, we focused our attention
on the cytokines/signaling pathways and proteins that
could be modulated by NF-κB, and about 57 DEGs modu-
lated by NF-κB activation were found to be differentially
expressed in the liver of FHF, including 47 up-regulated
genes and 10 down-regulated genes (Figure 4A); and the
direct interaction networks of those DEGs coding proteins
were also presented in Figure 4B. For example, the widely
concerned chemokines and its ligand in FHF (such as Cxcl
2, Ccl 2, Ccl 5, and et al) were significant observed in NF-
κB pathway analysis.
In this study, the mRNA and protein expression of
partial above-mentioned DEGs were also verified in
FHF mouse liver. And the level of NF-κBp65 protein
in FHF mouse liver were significantly elevated, about
5 times, compared with that in the healthy control mouse
(0.499 ± 0.034 vs.0.095 ± 0.013, P = 0.004) (Figure 5A). In-
teresting, the expression of IκBα protein (0.588 ± 0.002 vs.
0.086 ± 0.008, P = 0.000), a negative feedback regulate of
NF-κB, was also significantly increased about seven times
in liver tissues of mice with FHF (Figure 5A). The mRNA
Figure 4 The expression of DEGs regulated by NF-κB and their direct interaction in FHF library. (A) Cluster image of expression patterns
of DEGs that regulated by NF-κB. (B) Protein-protein direct interaction networks of NF-κB regulated DEGs.
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lyzed by quantitative PCR. As compared to normal control
mouse, the levels of NFκBie (0.189 ± 0.054 vs. 0.078 ±
0.169, P = 0.027), TNFα (0.361 ± 0.093 vs. 0.126 ± 0.015,
P = 0.012), IL1β (0.171 ± 0.003 vs. 0.047 ± 0.011, P = 0.000),
iNOS (9.439 ± 2.712 vs. 3.083 ± 0.391, P = 0.016), CCL3
(0.112 ± 0.025 vs. 0.040 ± 0.01, P = 0.009) and CCL4
(0.074 ± 0.008 vs. 0.032 ± 0.002, P = 0.001) genes were
significantly increased in hepatic tissues of FHF, and
the levels of Bid (0.117 ± 0.027 vs. 0.403 ± 0.078, P =
0.004), Bcl2(0.039 ± 0.004 vs. 0.106 ± 0.013, P = 0.001) and
Jub (0.46 ± 0.024 vs. 0.628 ± 0.062, P = 0.012) genes were
decreased in hepatic tissues of FHF(Figure 5B). The above
findings suggested that the significantly increased NF-κB
protein positively may affect the balance of various cyto-
kines in liver tissue, and participate in the aggravation of
endotoxin-induced liver injury.Pre-block of NF-κB significant alleviates hepatic pathological
damage and mortality of FHF mouse
To clarify whether increased NF-κB protein participate in
the occurrence and development of FHF, the expression of
NF-κB was pre-blocked by chemical inhibitor PDTC, 12 h
before the construction of experimental FHF mouse
model. As shown in Figure 6, NF-κB inhibition resulted in
remarkable improvement of biochemical parameters of
liver function, which was demonstrated by the lower levels
of serum ALT, AST, TBil and IBil in FHF as compared to
those in normal control mouse (Figure 6A). And H&E
staining and TUNEL assay results revealed that the hep-
atic apoptosis and necrosis was strongly suppressed in
FHF after NF-κB was pre-blocked by PDTC (Figure 6B).
Importantly, the cumulative 12-month survival rates of
FHF mice model was significantly increased from 20% to
100% when NF-κB was pre-blocked (Figure 6C).
Figure 5 Validations of NF-κB and its regulated DEGs in FHF liver samples. (A) The expression of NF-κB and its negative regulator IκBα by
Western blotting. (B) The mRNA levels of partial NF-κB regulated DEGs by qPCR.
Figure 6 Early administration of PDTC in alleviating hepatic pathological damage and preventing FHF occurrence. (A) The biochemical
parameters of liver function. (B) TUNEL assay H&E and staining results. (C) 12-hour cumulative survival rate. (D) The expression of TNFα and iNOS
detected by immunohistochemistry assay. (E) The serum protein levels of TNFα detected by ELISA. (F) The mRNA levels of TNFα and iNOS by qPCR.
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tive cells and intensity of the reaction of TNFα and
iNOS were obvious in liver tissue of FHF (Figure 6D);
and after NF-κB was pre-blocked, the expression of
TNFα and iNOS in liver tissue were both significantly
decreased (Figure 6D,E and F). In summary, our data
suggested that suppression of NF-κB activation or ex-
pression mediated by chemical inhibitor PDTC could
significantly improve liver function and reduce mortality
of FHF mouse model, and NF-κB would be a potential
new therapeutic target for FHF.
Discussion
At present, the exact mechanisms of the pathophysio-
logical events in the liver leading to FHF are not fully
understood, there is still no available particularly effect-
ive therapy except for liver transplantation; however, the
latter is also limited by a severe shortage of donor livers
[13]. Thus, there is an urgent need to explore new ef-
fective treatment measures. In past decade, some host
genes or their encoded moleculars (including cytokines
and chemokines) had been discovered that were associ-
ated with hepatocyte unnatural death and participated in
the occurrence of FHF [14]. However, the interactions of
vast majority of cytokines/chemokines with each other
remained unclear in the process of FHF.
Currently, detecting changes in gene expression of
host and their interaction networks have become an in-
creasingly important topic in FHF, and the genes differ-
entially expressed in FHF are of foremost interest to
both basic and clinical researches [15]. With the assist-
ance of the new-generation high throughput sequencing
technology, DGE has be employed to economically and
quickly capture the whole genome of the gene expres-
sion of certain tissue of a species under specific condi-
tions [16]. In this study, this technology was firstly used
to identify DEGs of mouse liver tissue under different
external stimuli conditions, and it was also the first re-
ported attempt to reveal the global network of DEGs in
FHF. It is worth to mention that our results have pro-
vided a variety of potential candidate targets for patho-
genic mechanism and new drug development of FHF,
and all raw data could be obtained in Additional file 1:
Table S1.
Though hepatotropic virus infection is the main cause
of FHF in clinical practice, there is still no hepatotropic
virus induced FHF animal model available at present,
which greatly limits the investigations of related molecu-
lar mechanisms and new treatment strategies of FHF. As
we know, the activation of hepatic macrophages and its-
associated inflammation are extremely common in pa-
tients with FHF, and this situation is largely related to
endotoxin exposure [17]. So, most scholars had to choose
endotoxin-induced animal model to conduct relatedresearch work on FHF in past years, though it has defects
in reflecting the role of hepatotropic virus in the patho-
genesis of massive hepatic necrosis. Based on this present
situation, the D-GalN/LPS-induced acute liver damage
mouse model has been used to yield the global gene
expression profile of FHF in present study; and a total of
3551 DEGs were successfully detected in liver tissue of
FHF, including 1366 up-regulated and 2185 down-
regulated DEGs. And majority of those detected DGEs
were strongly enriched metabolic process, biosynthetic
process, response to stimulus and response to stress. As
we know, liver is a multifunctional organ involved in im-
portant metabolic functions, synthesis of plasma proteins
and storage of lipids and retinol, and the failure of liver
function could result in serious metabolic disorder of
sugar, fat and protein. Thus the highly enriched metabolic
process observed in this study was consistent with the
objective fact. Although we did not conduct in-depth veri-
fication of the relevant DEGs on liver cellular metabolism,
the global interaction map of corresponding DEGs re-
ported in this study would provide important clues to fu-
ture studies.
Excessive apoptosis and abnormal necrosis are prom-
inent features of FHF [18]. According to analysis of bio-
logical process, high to 579 and 365 DEGs involved in
response to stimulus and response to stress, respectively.
To shed more lights into the function roles of genes re-
sponsible for the progression of FHF, we further investi-
gated the hepatocyte damage associated apoptosis and
chemokine signaling pathways by the enrichment ana-
lysis of DEGs among normal and FHF liver samples, and
found there were 39 DEGs in apoptosis pathway and 76
DEGs in chemokine signaling pathways. From the large
number of DEGs in above two-mentioned pathways, it’s
easy to see that inflammatory processes play a funda-
mental role in liver tissue damage, and the complexity of
inflammatory cytokine network involved in the occur-
rence and development of FHF. In recent years, many
in vitro and in vivo studies have examined the contribu-
tion of components of the NF-κB signaling pathways to
the regulation of liver cell damage and repair, in particu-
lar, of liver cell death and regeneration in liver damage
development [19,20]. However, the exact role of NF-κB
in FHF in vivo is still controversial [21]. In this study, ac-
cording to the clues provided by DGEP experiment, we
performed a cluster analysis of DEGs in NF-κB pathway,
and there were 32 DEGs up-regulated or down-
regulated in FHF. Additionally, the expression levels
of NF-κBp65 and IκBα proteins were both increased
significantly in liver tissue. So, we inferred that the ac-
tivation of NF-κB mediated signaling pathways played
important roles in the development of FHF. As the
gene transcription of IκBα was regulated by NF-κB,
the high expression of IκBα proteins in FHF could be
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the high expression of IκBα proteins in this experiment
may also execute a negative feedback regulation of NF-κB
overexpression in the development of FHF [22].
In this study, after the activation approach of NF-κB
were pre-blocked, we found that D-GalN/ LPS intraperito-
neal injection could not induce significantly liver damage
and all mouse survived. So we believed that the overex-
pression of NF-κB or highly activated NF-κB should
participate in the progression of liver damage to FHF.
Though the higher expression levels of NF-κB have
been reported to protect cells from apoptosis and necro-
sis in some vitro experiments [23], the overexpression of
NF-κB also would activate and enhance the host non-
specific and specific immune response, and therefore re-
sult in tissue injury and organ dysfunction [24]. As we
know, the biological function of certain molecules would
be affected by the changes of surrounding environment
of cells, so the vast difference between in vitro and
in vivo environment is likely to influence the functions
of NF-κB. So, we believe that the overexpression of NF-
κB should mediate or aggravate the liver cell necrosis in
the process of FHF. Considering that oxidative stress
also has been shown to aggravate the hepatotoxicity in-
duced by LPS/D-GalN and PDTC is also an antioxidant,
BAY-11-7082 (another inhibitor of NF-κB) also was used
to verify the function of NF-κB, and the result was in
good agreement with PDTC experiment (data unshown).
Previous studies showed NF-κB was able to bind pro-
moter and enhancer regions containing κB sites, and
TNFα, iNOS, IL-2, IL-6, IL-8, GM-CSF, ICAM-1, MHC-
1, TNFβ, Toll -like receptors, chemokines and chemo-
kine receptor (CR) were all regulated by NF-κB [25-27].
So in this study, the high-level expression of cytokines
(such as TNFα and iNOS) and chemokines were associ-
ated with the over-activated NF-κB complex, and their
direct and indirect damaging effects on liver cells also
partially contributed to the pathogenic role of NF-κB ac-
tivation [28].Conclusions
This study is the first genome-wide effort to investigate
the transcriptional changes in FHF development. Though
it is impossible to discuss the relevance and impact of all
genes and clusters that were differentially expressed in this
study, present study still demonstrates the possibility of
NF-κB gene as a potential therapeutic target for FHF.Ethical approval
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